This blood test screens for postpartum depression—before symptoms

Blood tests and depression. Certainly, not a diagnostic combination you’d expect.

The innovators at Dionysus Digital Health might change your mind.

The startup’s new AI-enabled genetic blood test, Enlighten, screens for postpartum depression (PPD). And it can be used before symptoms even set in.

PPD is the most common complication of childbirth and the leading cause of maternal death, so the potential impact here is huge. But how does the technology work in theory and in practice? Let’s take a closer look.

Read more

MedTech Pulse is a newsletter publication on innovation at the intersection of technology and medicine. Stay ahead with unique perspectives on industry news, the latest startup deals, infographics, and inspiring conversations.

Powered by